Novavax, Inc. (NASDAQ:NVAX) Jefferies Global Healthcare Conference Call June 8, 2023 9:00 AM ET Company Participants Jim Kelly - Chief Financial Officer Filip Dubovsky - Chief Medical Officer Conference Call Participants Roger Song - Jefferies Roger Song Alright. Welcome, everyone. Day 2 2023 Jefferies Healthcare Conference. My name is Roger Song, one of the senior biotech analysts in the U.S. Next presenting company is Novavax. Welcome Filip and Jim. Jim Kelly Alright. Roger Song Alright. So this is a fire ...

Novavax, Inc. (NASDAQ:NVAX) BofA Securities 2023 Health Care Conference May 11, 2023 1:00 PM ET Company Participants John Jacobs - President & Chief Executive Officer Filip Dubovsky - President-Research and Development Conference Call Participants Alec Stranahan - Vice President & Senior Biotech Analyst Alec Stranahan Hey, everyone. Good afternoon and welcome to -- or I guess good morning. Welcome to day three of the 2023 BofA Healthcare Conference. Thanks for joining the session with Novavax. My name is Al ...

Novavax, Inc. (NASDAQ:NVAX) Q1 2023 Earnings Conference Call May 9, 2023 8:30 AM ET Company Participants Erika Schultz - Senior Director of IR John Jacob - President & Chief Executive Officer Filip Dubovsky - Chief Medical Officer John Trizzino - Chief Commercial Officer & Chief Business Officer James Kelly - Chief Financial Officer & Treasurer Conference Call Participants Roger Song - Jefferies Eric Joseph - JPMorgan Mayank Mamtani - B. Riley Operator Good morning, and welcome to Novavax First Quarter 202 ...

Table of Contents NOVAVAX, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 21 Firstfield Road Gaithersburg MD 20878 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the t ...

Investor Presentation NASDAQ: NVAX | MARCH 2023 © 2023 NOVAVAX. All rights reserved. 1 Cautionary note regarding forward-looking statements This presentation includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. These forward-looking statements address various matters including information rel ...

© 2023 NOVAVAX. All rights reserved. 1 This presentation includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. These forward-looking statements address various matters including information relating to the future of Novavax, its key strategic priorities and commercial goals, its operating plan ...

Novavax, Inc. (NASDAQ:NVAX) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Erika Schultz - Senior Director of IR John Jacob - President and CEO John Trizzino - EVP and Chief Commercial Officer Filip Dubovsky - Chief Medical Officer James Kelly - EVP and CFO Rick Crowley - COO Conference Call Participants Roger Song - Jefferies Alec Stranahan - Bank of America Merrill Lynch Georgi Yordanov - Cowen and Company Eric Joseph - JPMorgan Mayank Mamtani - B. Riley Securities FBR ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No. 000-26770 NOVAVAX, INC. (Exact name of Registrant as specified in its charter) Delaware 22-2816046 (State of incorporation) (I.R.S. ...

Novavax, Inc. (NASDAQ:NVAX) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Silvia Taylor - Executive Vice President & Chief Communications Officer Stan Erck - President & Chief Executive Officer Filip Dubovsky - Chief Medical Officer John Trizzino - Chief Commercial Officer & Chief Business Officer Jim Kelly - Chief Financial Officer & Treasurer Conference Call Participants Roger Song - Jefferies Georgi Yordanov - Cowen and Company Mayank Mamtani - B. Riley Securities Alec ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q Commission File No. 000-26770 NOVAVAX, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 21 Firstfield Road Gaithersburg MD 20878 (Address of principal executive offices) (Zip code) (240) 268-2000 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whethe ...